
|Videos|March 28, 2016
Treatment Concerns: Financial Coverage
Advertisement
Episodes in this series

Advertisement
Related to this article

In the phase 3 MAVERICK trial, people with small cell lung cancer who had regular brain MRIs instead of preventive whole-brain radiation kept their memory and thinking intact longer, with no clear survival difference so far.

In a study of more than 250,000 older adults presented at ASTRO 2026, people with depression who started talk therapy within a week of their cancer diagnosis had a 27% lower risk of dying from their cancer. But most people with depression received no mental health treatment at all.

The FDA has approved Pixclara, the first FET-PET imaging agent for glioma in the U.S. Here's what it does, how accurate it is and why it matters for anyone waiting on an MRI result.

A study of more than 17,000 patients ages 23 to 64, presented at ASTRO 2026, found that only about 28% took endocrine therapy consistently for five years, and people who skipped radiation were more likely to fall off. Here's what to weigh before making that choice.
Advertisement
Advertisement
Trending on CURE
1
Why PSA Monitoring Matters After a Prostate Cancer Diagnosis
2
FDA Approves Tukysa Combination as Maintenance for HER2-Positive Breast Cancer
3
FDA Grants Breakthrough Therapy Designations to AbbVie's Temab-A in Colorectal and Lung Cancers
4
FDA Approves Tecentriq Plus Chemotherapy for Stage 3 dMMR Colon Cancer
5















